Achieve Life Sciences Inc. buy tbackenh
Start price
19.01.11
/
50%
€27,269
Target price
19.07.11
€33,000
Performance (%)
-10.45%
End price
19.07.11
€24,420
Summary
This prediction ended on 19.07.11 with a price of €24,420. The price of Achieve Life Sciences Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.45%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Achieve Life Sciences Inc. | 1.022% | 1.022% | -18.347% | -30.423% |
| iShares Core DAX® | -0.258% | 0.299% | 15.648% | 15.944% |
| iShares Nasdaq 100 | 2.964% | 4.660% | 32.001% | 57.194% |
| iShares Nikkei 225® | 1.217% | -2.160% | 6.668% | 4.285% |
| iShares S&P 500 | 1.732% | 2.807% | 25.596% | 48.530% |
Comments by tbackenh for this prediction
In the thread Achieve Life Sciences Inc diskutieren
Oncogenex Pharmaceutical
Oncogenex Pharmaceutical erscheint auf dem jetzigen Niveau gut unterstützt und der Aufwärtstrend der letzten Tage könnte sich weiter fortsetzen.
(Laufzeit überschritten)